SEC Form 4 · accession 0000899243-18-025656
ORAGENICS INC · OGEN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Fred Telling
Director
Period of report
Sep 27, 2018
Accepted (ET)
Oct 1, 2018 · 4:05 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001174940
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Employee Director Option (Right to Buy)F1 | $0.73 | Sep 27, 2018 | A | 125,000 | A | Sep 27, 2018 | Sep 27, 2028 | Common Stock | 125,000 | 125,000 | D |
Explanation of responses
- F1Represents an award of options to purchase shares of the Company's common stock under the Company's 2012 Equity Incentive Plan, as amended in connection with service to the Company as a director. The options vest immediately. The option exercise price is the closing price on the date of the grant, September 27, 2018.